Advertisement

Topics

PCSK9 inhibitors still too pricey, study finds

06:13 EDT 22 Aug 2017 | BioPharmaDive

An analysis published in JAMA found list prices for the cholesterol-lowering drugs would need to be reduced to meet cost-effectiveness thresholds. 

Original Article: PCSK9 inhibitors still too pricey, study finds

NEXT ARTICLE

More From BioPortfolio on "PCSK9 inhibitors still too pricey, study finds"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cholesterol
Cholesterol is a waxy steroid metabolite found in the cell membranes and transported in the blood plasma. It is an important structural component of mammalian cell membranes, where it is establishes proper membrane permeability and fluidity. Cholesterol ...